Advertisement

Index by author

May 01, 1990; Volume 253,Issue 2

A

  1. Abe, M

    1. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
      M Yoshioka, H Togashi, M Abe, T Ikeda, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 427-431;

  2. Adams, J U

    1. Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.
      J U Adams and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 483-489;

  3. Asano, M

    1. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 586-593;

B

  1. Bala, G A

    1. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
      R J Smith, L M Sam, J M Justen, G L Bundy, G A Bala and J E Bleasdale
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 688-697;

  2. Balduini, W

    1. Characterization of cholinergic muscarinic receptor-stimulated phosphoinositide metabolism in brain from immature rats.
      W Balduini, S D Murphy and L G Costa
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 573-579;

  3. Barnes, P J

    1. Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms.
      M Ichinose, M G Belvisi and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 594-599;

  4. Bass, A S

    1. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
      A S Bass
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 798-802;

  5. Baum, H P

    1. Evaluation of a potent inhibitor of subprimate and primate renins.
      J M Wood, S C Mah, H P Baum, M de Gasparo, F Cumin, H Rüeger and J Nussberger
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 513-517;

  6. Belvisi, M G

    1. Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms.
      M Ichinose, M G Belvisi and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 594-599;

  7. Bernardini, R

    1. Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat.
      A E Calogero, T C Kamilaris, R Bernardini, E O Johnson, G P Chrousos and P W Gold
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 729-737;

  8. Besseghir, K

    1. Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule. I. Accumulation in the isolated nonperfused tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 444-451;
    2. Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule. II. Reabsorption and secretion in the isolated perfused tubule.
      K Besseghir, J Y Chatton and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 452-460;

  9. Bijl, W A

    1. Neuropeptide processing in regional brain slices: effect of conformation and sequence.
      Z W Li, W A Bijl, J W van Nispen, K Brendel and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 851-857;

  10. Bleasdale, J E

    1. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
      R J Smith, L M Sam, J M Justen, G L Bundy, G A Bala and J E Bleasdale
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 688-697;

  11. Bowles, D K

    1. Protection against hypoxic injury in isolated-perfused rat heart by ruthenium red.
      Y Park, D K Bowles and J P Kehrer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 628-635;

  12. Brendel, K

    1. Neuropeptide processing in regional brain slices: effect of conformation and sequence.
      Z W Li, W A Bijl, J W van Nispen, K Brendel and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 851-857;

  13. Buck, K J

    1. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. I. Acute effects of ethanol.
      K J Buck and R A Harris
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 706-712;
    2. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol.
      K J Buck and R A Harris
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 713-719;

  14. Bundy, G L

    1. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
      R J Smith, L M Sam, J M Justen, G L Bundy, G A Bala and J E Bleasdale
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 688-697;

  15. Burks, T F

    1. Effects of bombesin on mucosal ion transport in the mouse isolated jejunum.
      P J Rivière, R J Sheldon, M E Malarchik, T F Burks and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 778-783;

C

  1. Calogero, A E

    1. Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat.
      A E Calogero, T C Kamilaris, R Bernardini, E O Johnson, G P Chrousos and P W Gold
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 729-737;

  2. Cancilla, P A

    1. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
      W M Pardridge, D Triguero, J Yang and P A Cancilla
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 884-891;

  3. Carlsson, S

    1. Differentiated responses of renal and adrenal sympathetic nerve activity to intravenous morphine administration in anesthetized rats.
      M Delle, P Thorén, J O Skarphedinsson, P Hoffman, S Carlsson and S Ricksten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 655-660;

  4. Carter, C J

    1. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
      C J Carter, K G Lloyd, B Zivkovic and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 475-482;

  5. Carvalho, A P

    1. Effect of ouabain on the gamma-[3H]aminobutyric acid uptake and release in the absence of Ca(+)+ and K(+)-depolarization.
      M S Santos, P P Gonçalves and A P Carvalho
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 620-627;

  6. Chatton, J Y

    1. Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule. II. Reabsorption and secretion in the isolated perfused tubule.
      K Besseghir, J Y Chatton and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 452-460;

  7. Chiodo, L A

    1. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.
      M D Kelland, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 803-811;

  8. Chrousos, G P

    1. Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat.
      A E Calogero, T C Kamilaris, R Bernardini, E O Johnson, G P Chrousos and P W Gold
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 729-737;

  9. Chung, S J

    1. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells.
      S J Chung and H L Fung
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 614-619;

  10. Church, J

    1. Cyclazocine and pentazocine as N-methylaspartate antagonists on cat and rat spinal neurons in vivo.
      J Church and D Lodge
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 636-645;

  11. Corwin, R L

    1. Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22 hr of food deprivation.
      R L Corwin, W L Woolverton and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 720-728;

  12. Costa, L G

    1. Characterization of cholinergic muscarinic receptor-stimulated phosphoinositide metabolism in brain from immature rats.
      W Balduini, S D Murphy and L G Costa
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 573-579;

  13. Cragoe, E J

    1. Influence of amiloride derivatives on alpha-1 adrenergic receptor-induced contractions of the rabbit aorta.
      C Lesburg, S Li, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 530-536;

  14. Cubeddu, L X

    1. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments.
      B M Faggin and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 812-818;

  15. Cumin, F

    1. Evaluation of a potent inhibitor of subprimate and primate renins.
      J M Wood, S C Mah, H P Baum, M de Gasparo, F Cumin, H Rüeger and J Nussberger
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 513-517;

  16. Curtis, A L

    1. Antidepressant actions on brain noradrenergic neurons.
      R J Valentino, A L Curtis, D G Parris and R G Wehby
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 833-840;

D

  1. Dan, T

    1. Mechanism of uricosuric action of AA-193 in DBA/2N mice.
      T Dan, H Tanaka and H Koga
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 437-443;

  2. Daniel, E E

    1. Inhibitory effects of amiloride on alpha adrenoceptors in canine vascular smooth muscle.
      A G Shi, Z L Wang, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 791-797;

  3. Danzebrink, R M

    1. Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception.
      R M Danzebrink and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 698-705;

  4. Davis, T P

    1. Neuropeptide processing in regional brain slices: effect of conformation and sequence.
      Z W Li, W A Bijl, J W van Nispen, K Brendel and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 851-857;

  5. de Gasparo, M

    1. Evaluation of a potent inhibitor of subprimate and primate renins.
      J M Wood, S C Mah, H P Baum, M de Gasparo, F Cumin, H Rüeger and J Nussberger
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 513-517;

  6. de la Lande, I S

    1. Failure of propranolol to inhibit the epinephrine-induced enhancement of responses to sympathetic nerve stimulation in the rat mesenteric vascular bed.
      P H Falckh, I S de la Lande, R E Stitzel, M Mano and R J Head
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 432-436;

  7. Delle, M

    1. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats.
      M Delle, S E Ricksten, J Häggendal, K Olsson, J O Skarphedinsson and P Thorén
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 646-654;
    2. Differentiated responses of renal and adrenal sympathetic nerve activity to intravenous morphine administration in anesthetized rats.
      M Delle, P Thorén, J O Skarphedinsson, P Hoffman, S Carlsson and S Ricksten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 655-660;

  8. Deth, R C

    1. Influence of amiloride derivatives on alpha-1 adrenergic receptor-induced contractions of the rabbit aorta.
      C Lesburg, S Li, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 530-536;
    2. Species differences in chlorethylclonidine antagonism at vascular alpha-1 adrenergic receptors.
      W N Tian, S Gupta and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 877-883;

  9. Devlin, T

    1. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
      T Devlin and W J Shoemaker
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 749-759;

  10. Duckles, S P

    1. Characterization of vascular muscarinic receptors: rabbit ear artery and bovine coronary artery.
      S P Duckles and A L Garcia-Villalon
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 608-613;

  11. Duffy, P

    1. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists.
      P W Kalivas, P Duffy and H Eberhardt
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 858-866;

E

  1. Eberhardt, H

    1. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists.
      P W Kalivas, P Duffy and H Eberhardt
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 858-866;

F

  1. Faggin, B M

    1. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments.
      B M Faggin and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 812-818;

  2. Falckh, P H

    1. Failure of propranolol to inhibit the epinephrine-induced enhancement of responses to sympathetic nerve stimulation in the rat mesenteric vascular bed.
      P H Falckh, I S de la Lande, R E Stitzel, M Mano and R J Head
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 432-436;

  3. Fischman, M W

    1. Effects of desipramine maintenance on cocaine self-administration by humans.
      M W Fischman, R W Foltin, G Nestadt and G D Pearlson
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 760-770;

  4. Foltin, R W

    1. Effects of desipramine maintenance on cocaine self-administration by humans.
      M W Fischman, R W Foltin, G Nestadt and G D Pearlson
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 760-770;

  5. Freeman, A S

    1. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.
      M D Kelland, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 803-811;

  6. Friedman, L K

    1. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures.
      L K Friedman and C Mytilineou
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 892-898;

  7. Fung, H L

    1. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells.
      S J Chung and H L Fung
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 614-619;

  8. Furlan, L E

    1. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
      L E Furlan, G Johnson, M Siegfried and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 525-529;

G

  1. Garcia-Villalon, A L

    1. Characterization of vascular muscarinic receptors: rabbit ear artery and bovine coronary artery.
      S P Duckles and A L Garcia-Villalon
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 608-613;

  2. Garcia-Villar, R

    1. [3H]idazoxan binding to the ovine myometrium. Binding characteristics and changes due to steroid hormones.
      A Vass-Lopez, R Garcia-Villar, M Lafontan and P L Toutain
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 819-824;

  3. Gebhart, G F

    1. Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception.
      R M Danzebrink and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 698-705;

  4. Gold, P W

    1. Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat.
      A E Calogero, T C Kamilaris, R Bernardini, E O Johnson, G P Chrousos and P W Gold
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 729-737;

  5. Gonçalves, P P

    1. Effect of ouabain on the gamma-[3H]aminobutyric acid uptake and release in the absence of Ca(+)+ and K(+)-depolarization.
      M S Santos, P P Gonçalves and A P Carvalho
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 620-627;

  6. Grider, J R

    1. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum.
      J R Grider and J R Rivier
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 738-742;

  7. Gupta, S

    1. Species differences in chlorethylclonidine antagonism at vascular alpha-1 adrenergic receptors.
      W N Tian, S Gupta and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 877-883;

H

  1. Häggendal, J

    1. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats.
      M Delle, S E Ricksten, J Häggendal, K Olsson, J O Skarphedinsson and P Thorén
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 646-654;

  2. Harrington, B

    1. Age-related changes in enteric neuromuscular transmission.
      T V Nowak, B Harrington and J Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 683-687;

  3. Harris, R A

    1. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. I. Acute effects of ethanol.
      K J Buck and R A Harris
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 706-712;
    2. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol.
      K J Buck and R A Harris
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 713-719;

  4. Hartl, K S

    1. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
      W A Schumacher, C L Heran, K S Hartl and M L Ogletree
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 841-846;

  5. Hashimoto, H

    1. Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.
      H Hashimoto, N Satoh, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 552-557;

  6. Head, R J

    1. Failure of propranolol to inhibit the epinephrine-induced enhancement of responses to sympathetic nerve stimulation in the rat mesenteric vascular bed.
      P H Falckh, I S de la Lande, R E Stitzel, M Mano and R J Head
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 432-436;

  7. Heller, L J

    1. Adenosine receptor antagonism attenuates angiotensin II effects on adrenergic neurotransmission in the rabbit isolated vas deferens.
      G J Trachte and L J Heller
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 490-496;

  8. Heran, C L

    1. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
      W A Schumacher, C L Heran, K S Hartl and M L Ogletree
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 841-846;

  9. Hoffman, P

    1. Differentiated responses of renal and adrenal sympathetic nerve activity to intravenous morphine administration in anesthetized rats.
      M Delle, P Thorén, J O Skarphedinsson, P Hoffman, S Carlsson and S Ricksten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 655-660;

  10. Holtzman, S G

    1. Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.
      J U Adams and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 483-489;

  11. Hong, J S

    1. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus.
      P H Lee, C W Xie, D V Lewis, W A Wilson, C L Mitchell and J S Hong
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 545-551;

  12. Hu, S L

    1. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
      S L Hu, H S Kim, P Okolie and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 771-777;

I

  1. Ichinose, M

    1. Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms.
      M Ichinose, M G Belvisi and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 594-599;

  2. Ikeda, T

    1. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
      M Yoshioka, H Togashi, M Abe, T Ikeda, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 427-431;

  3. Imaizumi, Y

    1. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 586-593;

J

  1. Jiang, Q

    1. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
      Q Jiang, R J Sheldon and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 784-790;

  2. Johnson, E O

    1. Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat.
      A E Calogero, T C Kamilaris, R Bernardini, E O Johnson, G P Chrousos and P W Gold
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 729-737;

  3. Johnson, G

    1. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
      L E Furlan, G Johnson, M Siegfried and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 525-529;

  4. Justen, J M

    1. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
      R J Smith, L M Sam, J M Justen, G L Bundy, G A Bala and J E Bleasdale
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 688-697;

K

  1. Kalbfleisch, J

    1. Age-related changes in enteric neuromuscular transmission.
      T V Nowak, B Harrington and J Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 683-687;

  2. Kaley, G

    1. Similarities in the pharmacological modulation of reactive hyperemia and vasodilation to hydrogen peroxide in rat skeletal muscle arterioles: effects of probes for endothelium-derived mediators.
      M S Wolin, J M Rodenburg, E J Messina and G Kaley
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 508-512;

  3. Kalivas, P W

    1. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists.
      P W Kalivas, P Duffy and H Eberhardt
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 858-866;

  4. Kameyama, T

    1. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
      A Katoh, T Nabeshima and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 600-607;

  5. Kamilaris, T C

    1. Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat.
      A E Calogero, T C Kamilaris, R Bernardini, E O Johnson, G P Chrousos and P W Gold
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 729-737;

  6. Katoh, A

    1. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
      A Katoh, T Nabeshima and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 600-607;

  7. Katz, J L

    1. Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys.
      J M Witkin, G A Ricaurte and J L Katz
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 466-474;

  8. Kehrer, J P

    1. Protection against hypoxic injury in isolated-perfused rat heart by ruthenium red.
      Y Park, D K Bowles and J P Kehrer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 628-635;

  9. Kelland, M D

    1. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.
      M D Kelland, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 803-811;

  10. Keller, R W

    1. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
      G L Snyder, R W Keller and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 867-876;

  11. Kim, H S

    1. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
      S L Hu, H S Kim, P Okolie and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 771-777;

  12. Koga, H

    1. Mechanism of uricosuric action of AA-193 in DBA/2N mice.
      T Dan, H Tanaka and H Koga
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 437-443;

  13. Kondo, S

    1. Autonomic receptors in urinary tract: sex and age differences.
      J Latifpour, S Kondo, B O'Hollaren, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 661-667;

  14. Kuriyama, K

    1. Functional modulation of cerebral gamma-aminobutyric acidA receptor/benzodiazepine receptor/chloride ion channel complex with ethyl beta-carboline-3-carboxylate: presence of independent binding site for ethyl beta-carboline-3-carboxylate.
      J Taguchi and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 558-566;

  15. Kwan, C Y

    1. Inhibitory effects of amiloride on alpha adrenoceptors in canine vascular smooth muscle.
      A G Shi, Z L Wang, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 791-797;

L

  1. Lafontan, M

    1. [3H]idazoxan binding to the ovine myometrium. Binding characteristics and changes due to steroid hormones.
      A Vass-Lopez, R Garcia-Villar, M Lafontan and P L Toutain
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 819-824;

  2. Latifpour, J

    1. Autonomic receptors in urinary tract: sex and age differences.
      J Latifpour, S Kondo, B O'Hollaren, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 661-667;

  3. Lee, P H

    1. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus.
      P H Lee, C W Xie, D V Lewis, W A Wilson, C L Mitchell and J S Hong
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 545-551;

  4. Lefer, A M

    1. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
      L E Furlan, G Johnson, M Siegfried and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 525-529;

  5. Leli, U

    1. Effects of a choline-deficient ethionine-supplemented diet on phospholipase C activity in mouse pancreatic acinar cell membranes and in electropermeabilized mouse pancreatic acini.
      U Leli, A Saluja, L Picard, A Zavertnik and M L Steer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 847-850;

  6. Lesburg, C

    1. Influence of amiloride derivatives on alpha-1 adrenergic receptor-induced contractions of the rabbit aorta.
      C Lesburg, S Li, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 530-536;

  7. Lewis, D V

    1. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus.
      P H Lee, C W Xie, D V Lewis, W A Wilson, C L Mitchell and J S Hong
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 545-551;

  8. Li, S

    1. Influence of amiloride derivatives on alpha-1 adrenergic receptor-induced contractions of the rabbit aorta.
      C Lesburg, S Li, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 530-536;

  9. Li, Z W

    1. Neuropeptide processing in regional brain slices: effect of conformation and sequence.
      Z W Li, W A Bijl, J W van Nispen, K Brendel and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 851-857;

  10. Lloyd, K G

    1. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
      C J Carter, K G Lloyd, B Zivkovic and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 475-482;

  11. Lodge, D

    1. Cyclazocine and pentazocine as N-methylaspartate antagonists on cat and rat spinal neurons in vivo.
      J Church and D Lodge
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 636-645;

M

  1. Maekawa, T

    1. Membrane potential-dependent and carrier-mediated transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver plasma membrane vesicles.
      I Tamai, T Maekawa and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 537-544;

  2. Mah, S C

    1. Evaluation of a potent inhibitor of subprimate and primate renins.
      J M Wood, S C Mah, H P Baum, M de Gasparo, F Cumin, H Rüeger and J Nussberger
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 513-517;

  3. Malarchik, M E

    1. Effects of bombesin on mucosal ion transport in the mouse isolated jejunum.
      P J Rivière, R J Sheldon, M E Malarchik, T F Burks and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 778-783;

  4. Malik, K U

    1. Effect of protein kinase C inhibitors on the actions of phorbol esters on vascular tone and adrenergic transmission in the isolated rat kidney.
      E Sehic and K U Malik
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 497-507;

  5. Mano, M

    1. Failure of propranolol to inhibit the epinephrine-induced enhancement of responses to sympathetic nerve stimulation in the rat mesenteric vascular bed.
      P H Falckh, I S de la Lande, R E Stitzel, M Mano and R J Head
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 432-436;

  6. Masuzawa, K

    1. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 586-593;

  7. Matsuda, T

    1. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 586-593;

  8. Matsumoto, M

    1. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
      M Yoshioka, H Togashi, M Abe, T Ikeda, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 427-431;

  9. Mecca, T E

    1. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
      R H Zobrist and T E Mecca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 461-465;

  10. Messina, E J

    1. Similarities in the pharmacological modulation of reactive hyperemia and vasodilation to hydrogen peroxide in rat skeletal muscle arterioles: effects of probes for endothelium-derived mediators.
      M S Wolin, J M Rodenburg, E J Messina and G Kaley
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 508-512;

  11. Mitchell, C L

    1. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus.
      P H Lee, C W Xie, D V Lewis, W A Wilson, C L Mitchell and J S Hong
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 545-551;

  12. Mondal, G

    1. Effect of ouabain on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic rather than alpha adrenergic receptors.
      Z Xu, G Mondal, J P Song and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 668-675;

  13. Morita, T

    1. Autonomic receptors in urinary tract: sex and age differences.
      J Latifpour, S Kondo, B O'Hollaren, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 661-667;

  14. Mosig, D

    1. Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule. I. Accumulation in the isolated nonperfused tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 444-451;

  15. Murphy, S D

    1. Characterization of cholinergic muscarinic receptor-stimulated phosphoinositide metabolism in brain from immature rats.
      W Balduini, S D Murphy and L G Costa
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 573-579;

  16. Mytilineou, C

    1. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures.
      L K Friedman and C Mytilineou
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 892-898;

N

  1. Nabeshima, T

    1. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
      A Katoh, T Nabeshima and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 600-607;

  2. Nakashima, M

    1. Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.
      H Hashimoto, N Satoh, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 552-557;

  3. Nelson, S D

    1. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
      D Thomassen, J T Slattery and S D Nelson
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 567-572;

  4. Nestadt, G

    1. Effects of desipramine maintenance on cocaine self-administration by humans.
      M W Fischman, R W Foltin, G Nestadt and G D Pearlson
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 760-770;

  5. Neugarten, J

    1. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
      J Yoo, D Schlondorff and J Neugarten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 743-748;

  6. Nowak, T V

    1. Age-related changes in enteric neuromuscular transmission.
      T V Nowak, B Harrington and J Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 683-687;

  7. Nussberger, J

    1. Evaluation of a potent inhibitor of subprimate and primate renins.
      J M Wood, S C Mah, H P Baum, M de Gasparo, F Cumin, H Rüeger and J Nussberger
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 513-517;

O

  1. O'Hollaren, B

    1. Autonomic receptors in urinary tract: sex and age differences.
      J Latifpour, S Kondo, B O'Hollaren, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 661-667;

  2. Ogletree, M L

    1. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
      W A Schumacher, C L Heran, K S Hartl and M L Ogletree
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 841-846;

  3. Ohya, Y

    1. Tocolytic agents act on calcium channel current in single smooth muscle cells of pregnant rat uterus.
      Y Ohya and N Sperelakis
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 580-585;

  4. Okamura, T

    1. Beta adrenoceptor subtype in isolated human, monkey and dog epicardial coronary arteries.
      N Toda and T Okamura
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 518-524;
    2. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries.
      N Toda and T Okamura
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 676-682;

  5. Okolie, P

    1. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
      S L Hu, H S Kim, P Okolie and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 771-777;

  6. Olsson, K

    1. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats.
      M Delle, S E Ricksten, J Häggendal, K Olsson, J O Skarphedinsson and P Thorén
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 646-654;

P

  1. Pardridge, W M

    1. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
      W M Pardridge, D Triguero, J Yang and P A Cancilla
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 884-891;

  2. Park, Y

    1. Protection against hypoxic injury in isolated-perfused rat heart by ruthenium red.
      Y Park, D K Bowles and J P Kehrer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 628-635;

  3. Parris, D G

    1. Antidepressant actions on brain noradrenergic neurons.
      R J Valentino, A L Curtis, D G Parris and R G Wehby
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 833-840;

  4. Pearlson, G D

    1. Effects of desipramine maintenance on cocaine self-administration by humans.
      M W Fischman, R W Foltin, G Nestadt and G D Pearlson
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 760-770;

  5. Picard, L

    1. Effects of a choline-deficient ethionine-supplemented diet on phospholipase C activity in mouse pancreatic acinar cell membranes and in electropermeabilized mouse pancreatic acini.
      U Leli, A Saluja, L Picard, A Zavertnik and M L Steer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 847-850;

  6. Porreca, F

    1. Effects of bombesin on mucosal ion transport in the mouse isolated jejunum.
      P J Rivière, R J Sheldon, M E Malarchik, T F Burks and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 778-783;
    2. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
      Q Jiang, R J Sheldon and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 784-790;

  7. Purdy, R E

    1. Effect of ouabain on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic rather than alpha adrenergic receptors.
      Z Xu, G Mondal, J P Song and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 668-675;

R

  1. Ricaurte, G A

    1. Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys.
      J M Witkin, G A Ricaurte and J L Katz
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 466-474;

  2. Ricksten, S

    1. Differentiated responses of renal and adrenal sympathetic nerve activity to intravenous morphine administration in anesthetized rats.
      M Delle, P Thorén, J O Skarphedinsson, P Hoffman, S Carlsson and S Ricksten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 655-660;

  3. Ricksten, S E

    1. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats.
      M Delle, S E Ricksten, J Häggendal, K Olsson, J O Skarphedinsson and P Thorén
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 646-654;

  4. Rivier, J R

    1. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum.
      J R Grider and J R Rivier
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 738-742;

  5. Rivière, P J

    1. Effects of bombesin on mucosal ion transport in the mouse isolated jejunum.
      P J Rivière, R J Sheldon, M E Malarchik, T F Burks and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 778-783;

  6. Roch-Ramel, F

    1. Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule. I. Accumulation in the isolated nonperfused tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 444-451;
    2. Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule. II. Reabsorption and secretion in the isolated perfused tubule.
      K Besseghir, J Y Chatton and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 452-460;

  7. Rodenburg, J M

    1. Similarities in the pharmacological modulation of reactive hyperemia and vasodilation to hydrogen peroxide in rat skeletal muscle arterioles: effects of probes for endothelium-derived mediators.
      M S Wolin, J M Rodenburg, E J Messina and G Kaley
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 508-512;

  8. Rüeger, H

    1. Evaluation of a potent inhibitor of subprimate and primate renins.
      J M Wood, S C Mah, H P Baum, M de Gasparo, F Cumin, H Rüeger and J Nussberger
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 513-517;

S

  1. Saito, H

    1. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
      M Yoshioka, H Togashi, M Abe, T Ikeda, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 427-431;

  2. Saluja, A

    1. Effects of a choline-deficient ethionine-supplemented diet on phospholipase C activity in mouse pancreatic acinar cell membranes and in electropermeabilized mouse pancreatic acini.
      U Leli, A Saluja, L Picard, A Zavertnik and M L Steer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 847-850;

  3. Sam, L M

    1. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
      R J Smith, L M Sam, J M Justen, G L Bundy, G A Bala and J E Bleasdale
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 688-697;

  4. Santos, M S

    1. Effect of ouabain on the gamma-[3H]aminobutyric acid uptake and release in the absence of Ca(+)+ and K(+)-depolarization.
      M S Santos, P P Gonçalves and A P Carvalho
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 620-627;

  5. Satoh, N

    1. Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.
      H Hashimoto, N Satoh, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 552-557;

  6. Scatton, B

    1. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
      C J Carter, K G Lloyd, B Zivkovic and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 475-482;

  7. Schlondorff, D

    1. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
      J Yoo, D Schlondorff and J Neugarten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 743-748;

  8. Schumacher, W A

    1. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
      W A Schumacher, C L Heran, K S Hartl and M L Ogletree
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 841-846;

  9. Schuster, C R

    1. Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22 hr of food deprivation.
      R L Corwin, W L Woolverton and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 720-728;

  10. Sehic, E

    1. Effect of protein kinase C inhibitors on the actions of phorbol esters on vascular tone and adrenergic transmission in the isolated rat kidney.
      E Sehic and K U Malik
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 497-507;

  11. Sheldon, R J

    1. Effects of bombesin on mucosal ion transport in the mouse isolated jejunum.
      P J Rivière, R J Sheldon, M E Malarchik, T F Burks and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 778-783;
    2. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
      Q Jiang, R J Sheldon and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 784-790;

  12. Shi, A G

    1. Inhibitory effects of amiloride on alpha adrenoceptors in canine vascular smooth muscle.
      A G Shi, Z L Wang, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 791-797;

  13. Shoemaker, W J

    1. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
      T Devlin and W J Shoemaker
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 749-759;

  14. Siegfried, M

    1. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
      L E Furlan, G Johnson, M Siegfried and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 525-529;

  15. Simon, C

    1. Regulation of serotonin release from enterochromaffin cells of rat cecum mucosa.
      C Simon and J P Ternaux
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 825-832;

  16. Skarphedinsson, J O

    1. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats.
      M Delle, S E Ricksten, J Häggendal, K Olsson, J O Skarphedinsson and P Thorén
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 646-654;
    2. Differentiated responses of renal and adrenal sympathetic nerve activity to intravenous morphine administration in anesthetized rats.
      M Delle, P Thorén, J O Skarphedinsson, P Hoffman, S Carlsson and S Ricksten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 655-660;

  17. Slattery, J T

    1. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
      D Thomassen, J T Slattery and S D Nelson
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 567-572;

  18. Smith, R J

    1. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
      R J Smith, L M Sam, J M Justen, G L Bundy, G A Bala and J E Bleasdale
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 688-697;

  19. Snyder, G L

    1. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
      G L Snyder, R W Keller and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 867-876;

  20. Song, J P

    1. Effect of ouabain on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic rather than alpha adrenergic receptors.
      Z Xu, G Mondal, J P Song and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 668-675;

  21. Sperelakis, N

    1. Tocolytic agents act on calcium channel current in single smooth muscle cells of pregnant rat uterus.
      Y Ohya and N Sperelakis
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 580-585;

  22. Steer, M L

    1. Effects of a choline-deficient ethionine-supplemented diet on phospholipase C activity in mouse pancreatic acinar cell membranes and in electropermeabilized mouse pancreatic acini.
      U Leli, A Saluja, L Picard, A Zavertnik and M L Steer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 847-850;

  23. Stitzel, R E

    1. Failure of propranolol to inhibit the epinephrine-induced enhancement of responses to sympathetic nerve stimulation in the rat mesenteric vascular bed.
      P H Falckh, I S de la Lande, R E Stitzel, M Mano and R J Head
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 432-436;

T

  1. Taguchi, J

    1. Functional modulation of cerebral gamma-aminobutyric acidA receptor/benzodiazepine receptor/chloride ion channel complex with ethyl beta-carboline-3-carboxylate: presence of independent binding site for ethyl beta-carboline-3-carboxylate.
      J Taguchi and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 558-566;

  2. Takiguchi, Y

    1. Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.
      H Hashimoto, N Satoh, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 552-557;

  3. Tamai, I

    1. Membrane potential-dependent and carrier-mediated transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver plasma membrane vesicles.
      I Tamai, T Maekawa and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 537-544;

  4. Tanaka, H

    1. Mechanism of uricosuric action of AA-193 in DBA/2N mice.
      T Dan, H Tanaka and H Koga
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 437-443;

  5. Ternaux, J P

    1. Regulation of serotonin release from enterochromaffin cells of rat cecum mucosa.
      C Simon and J P Ternaux
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 825-832;

  6. Thomassen, D

    1. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
      D Thomassen, J T Slattery and S D Nelson
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 567-572;

  7. Thorén, P

    1. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats.
      M Delle, S E Ricksten, J Häggendal, K Olsson, J O Skarphedinsson and P Thorén
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 646-654;
    2. Differentiated responses of renal and adrenal sympathetic nerve activity to intravenous morphine administration in anesthetized rats.
      M Delle, P Thorén, J O Skarphedinsson, P Hoffman, S Carlsson and S Ricksten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 655-660;

  8. Tian, W N

    1. Species differences in chlorethylclonidine antagonism at vascular alpha-1 adrenergic receptors.
      W N Tian, S Gupta and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 877-883;

  9. Toda, N

    1. Beta adrenoceptor subtype in isolated human, monkey and dog epicardial coronary arteries.
      N Toda and T Okamura
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 518-524;
    2. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries.
      N Toda and T Okamura
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 676-682;

  10. Togashi, H

    1. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
      M Yoshioka, H Togashi, M Abe, T Ikeda, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 427-431;

  11. Toutain, P L

    1. [3H]idazoxan binding to the ovine myometrium. Binding characteristics and changes due to steroid hormones.
      A Vass-Lopez, R Garcia-Villar, M Lafontan and P L Toutain
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 819-824;

  12. Trachte, G J

    1. Adenosine receptor antagonism attenuates angiotensin II effects on adrenergic neurotransmission in the rabbit isolated vas deferens.
      G J Trachte and L J Heller
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 490-496;

  13. Triguero, D

    1. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
      W M Pardridge, D Triguero, J Yang and P A Cancilla
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 884-891;

  14. Tsuji, A

    1. Membrane potential-dependent and carrier-mediated transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver plasma membrane vesicles.
      I Tamai, T Maekawa and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 537-544;

V

  1. Valentino, R J

    1. Antidepressant actions on brain noradrenergic neurons.
      R J Valentino, A L Curtis, D G Parris and R G Wehby
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 833-840;

  2. van Nispen, J W

    1. Neuropeptide processing in regional brain slices: effect of conformation and sequence.
      Z W Li, W A Bijl, J W van Nispen, K Brendel and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 851-857;

  3. Vass-Lopez, A

    1. [3H]idazoxan binding to the ovine myometrium. Binding characteristics and changes due to steroid hormones.
      A Vass-Lopez, R Garcia-Villar, M Lafontan and P L Toutain
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 819-824;

W

  1. Wang, Z L

    1. Inhibitory effects of amiloride on alpha adrenoceptors in canine vascular smooth muscle.
      A G Shi, Z L Wang, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 791-797;

  2. Watanabe, M

    1. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 586-593;

  3. Wehby, R G

    1. Antidepressant actions on brain noradrenergic neurons.
      R J Valentino, A L Curtis, D G Parris and R G Wehby
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 833-840;

  4. Weiss, G B

    1. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
      S L Hu, H S Kim, P Okolie and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 771-777;

  5. Weiss, R M

    1. Autonomic receptors in urinary tract: sex and age differences.
      J Latifpour, S Kondo, B O'Hollaren, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 661-667;

  6. Wilson, W A

    1. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus.
      P H Lee, C W Xie, D V Lewis, W A Wilson, C L Mitchell and J S Hong
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 545-551;

  7. Witkin, J M

    1. Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys.
      J M Witkin, G A Ricaurte and J L Katz
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 466-474;

  8. Wolin, M S

    1. Similarities in the pharmacological modulation of reactive hyperemia and vasodilation to hydrogen peroxide in rat skeletal muscle arterioles: effects of probes for endothelium-derived mediators.
      M S Wolin, J M Rodenburg, E J Messina and G Kaley
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 508-512;

  9. Wood, J M

    1. Evaluation of a potent inhibitor of subprimate and primate renins.
      J M Wood, S C Mah, H P Baum, M de Gasparo, F Cumin, H Rüeger and J Nussberger
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 513-517;

  10. Woolverton, W L

    1. Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22 hr of food deprivation.
      R L Corwin, W L Woolverton and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 720-728;

X

  1. Xie, C W

    1. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus.
      P H Lee, C W Xie, D V Lewis, W A Wilson, C L Mitchell and J S Hong
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 545-551;

  2. Xu, Z

    1. Effect of ouabain on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic rather than alpha adrenergic receptors.
      Z Xu, G Mondal, J P Song and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 668-675;

Y

  1. Yang, J

    1. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
      W M Pardridge, D Triguero, J Yang and P A Cancilla
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 884-891;

  2. Yoo, J

    1. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
      J Yoo, D Schlondorff and J Neugarten
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 743-748;

  3. Yoshioka, M

    1. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
      M Yoshioka, H Togashi, M Abe, T Ikeda, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 427-431;

Z

  1. Zavertnik, A

    1. Effects of a choline-deficient ethionine-supplemented diet on phospholipase C activity in mouse pancreatic acinar cell membranes and in electropermeabilized mouse pancreatic acini.
      U Leli, A Saluja, L Picard, A Zavertnik and M L Steer
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 847-850;

  2. Zigmond, M J

    1. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
      G L Snyder, R W Keller and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 867-876;

  3. Zivkovic, B

    1. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
      C J Carter, K G Lloyd, B Zivkovic and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 475-482;

  4. Zobrist, R H

    1. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
      R H Zobrist and T E Mecca
      Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 461-465;
Back to top

In this issue

Advertisement